ABIRATERON Devatis cpr pell 500 mg 56 pce

7680689810010 CH-68981 L02BX03 07.16.2.

Reimbursement limitations:

ABIRATDevat2

Substitution préparation originale/générique
Aucune nouvelle garantie de prise en charge n'est nécessaire pour le traitement …

ABIRATERON Devatis cpr pell 500 mg 56 pce
ABIRATERON Devatis cpr pell 500 mg 56 pce
ABIRATERON Devatis cpr pell 500 mg 56 pce
1 / 3
google

Details

Product number
6898101
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
abirateroni acetas 500 mg, lactosum monohydricum 253.2 mg, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 12.0 mg.

Articles (1)

Abirateron Devatis 500 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/01/2024
Patient information leaflet
Français
17/01/2024
Patient information leaflet
Italien
17/01/2024
Professional SmPC
Allemand
17/01/2024
Professional SmPC
Français
17/01/2024
Professional SmPC
Italien
17/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
253.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
12.0 MG Substance HBESI

Reimbursement information

Public price
CHF 899.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2024

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
68981
Drug name
Abirateron Devatis, Filmtabletten
Galenic form
FILM
ATC Code
L02BX03
Authorization status
Z
Dispensation category
B
First authorization
04/10/2023
Authorization expiration date
03/10/2028
IT number
07.16.2.
Domain
Human medicine
Field of application
Prostatakarzinom

Packaging details

Description (FR)
ABIRATERON Devatis cpr pell 500 mg 56 pce
Description (DE)
ABIRATERON Devatis Filmtabl 500 mg 56 Stk
Market launch
04/10/2023
Narcotic (BTM)
No

Original drug

Zytiga, Filmtabletten
CHF 2406.15
View original